Page last updated: 2024-08-26

nicotine and Carcinoma, Squamous Cell of Head and Neck

nicotine has been researched along with Carcinoma, Squamous Cell of Head and Neck in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hsueh, CY; Huang, Q; Ji, M; Shen, Y; Zhou, L1
Eguchi, T; Ibaragi, S; Kawai, H; Kodama, S; Kuwajima, D; Nagatsuka, H; Nishioka, T; Obata, K; Okamoto, K; Okui, T; Ono, K; Sasaki, A; Shimizu, R; Takabatake, K1

Other Studies

2 other study(ies) available for nicotine and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas.
    BMC cancer, 2022, Oct-25, Volume: 22, Issue:1

    Topics: Head and Neck Neoplasms; Humans; Nicotine; Prognosis; Receptors, Nicotinic; Smoking; Squamous Cell Carcinoma of Head and Neck

2022
Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
    International journal of oncology, 2019, Volume: 54, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Cetuximab; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mice; Nicotine; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Nicotinic; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases

2019